BMC Nephrology

Table 7 Preference-based quality of life scores (utilities) and quality adjusted life years (QALYs)

From: Nurse-led advance care planning with older people who have end-stage kidney disease: feasibility of a deferred entry randomised controlled trial incorporating an economic evaluation and mixed methods process evaluation (ACReDiT)

SF-6D utility	Immediate (n = 13)				Deferred (n = 13)
	Baseline (T1)		12 weeks (T3)		Baseline (T1)		12 weeks (T3)		Difference between groups
	Mean	SD	Mean	SD	Mean	SD	Mean	SD	Mean^a	95%CI
	0.69	0.09	0.68	0.11	0.68	0.15	0.71	0.13	−0.05	−0.15 to 0.05
QALYs	Immediate (n = 13)				Deferred (n = 13)
	12 weeks (T3)				12 weeks (T3)				Difference between groups
	Mean		SD		Mean		SD		Mean	95%CI
	0.12		0.07		0.13		0.07		−0.005	−0.06 to 0.06

^aDifference between groups adjusted for baseline values

Back to article page

ISSN: 1471-2369

Contact us

Submission enquiries: bmcnephrology@biomedcentral.com
General enquiries: ORSupport@springernature.com